A Phase 1, Double-Blind, Randomized, Placebo-Controlled, Sequential, Multiple Ascending-Dose Study to Evaluate the Pharmacokinetics and Pharmacodynamics of TAK-875 in Subjects With Type 2 Diabetes
收藏DataCite Commons2025-03-04 更新2026-05-07 收录
下载链接：
https://search.vivli.org/doiLanding/studies/00002514/isLanding
下载链接
链接失效反馈官方服务：
资源简介：
The purpose of this study is to evaluate the safety, tolerability, pharmacokinetics and pharmacodynamics of multiple ascending-doses of TAK-875 in subjects with type 2 diabetes mellitus.
本研究旨在评估多次递增剂量TAK-875在2型糖尿病（type 2 diabetes mellitus）受试者中的安全性、耐受性、药代动力学（pharmacokinetics）与药效动力学（pharmacodynamics）
提供机构：
Vivli
创建时间：
2018-10-27
